PIA Overview:

Cognition

Executive Committee

Chair: Andreas Monsch
Vice Chair: Douglas Galasko
Programs Chair: Mark Bondi
Communications Chair: David Salmon

Advances in cognitive science and cognitive neuroscience provide an opportunity to obtain new insights into Alzheimer’s disease (AD) and related disorders and to develop more effective ways to evaluate cognitive changes. Cognitive assessments are crucial for the diagnosis of neurocognitive disorders, for the evaluation of putative clinical trial effects, and for treatment planning. These assessments also provide an important basis for counseling of patients and families. The Cognition PIA aims to convene neuropsychologists, behavioral neurologists, and geriatric psychiatrists who are the world’s most prominent basic and clinical researchers on cognitive underpinnings of AD and related disorders to exchange information, discuss brain-cognition relationships, and establish an international consensus on cognitive “tools” for diagnostic assessment and treatment outcomes.

The Cognition PIA comprises four standing committees:

• Programs (Mark Bondi)
• Publications (David Salmon)
• Industry Liaison (Andreas Monsch)
• Education

As of 2018, the Cognition PIA has decided to address the following topics:

1. Harmonization of neuropsychological tests
2. Computerized tests / digital cognitive markers
3. Cross-cultural cognition
4. Development and validation of cognitive tools
5. Critical review of criteria for MCI and DSM-5
6. Cognitive screening
7. Longitudinal cognitive assessment
8. Cognition and EEG, MRI, etc.
9. Best practice of cognition in studies
10. Data sharing
11. Life-span view of cognition
12. Cognition and function

Join the Cognition LinkedIn group to be part of the conversation. 

On Twitter? Follow @ISTAART and use #CognitionPIA to share news.